CRC - Atlas of Metabolic Diseases
Organization: | CRC |
Publication Date: | 26 August 2005 |
Page Count: | 783 |
scope:
Preface
This book is designed as a source of practical information of
use in the diagnosis and management of patients with inherited
diseases of metabolism. We have kept the focus, as did Garrod, on
the inborn errors. This permits a unity of theme. At the same time,
the reality is that genetically-determin
We want this book to be helpful to physicians at the bedside, in
the intensive care unit and in the clinics and offices, as well as
to biochemical geneticists and clinical chemists involved in
laboratory diagnosis. The atlas format has permitted us to include
very many illustrations of patients.Metabolic pathways have been
shown with a reductionist or high power view of just that area most
relevant to each disease. In addition, the chapters deal with
individual diseases. There are introductory chapters to the organic
acidemias, the disorders of the urea cycle, the disorders of fatty
acid oxidation, the lactic acidemias, the glycogenoses and the
mucopolysaccharidose
The rates of discovery of new or previously unrecognized diseases in this field are enormous. In the 1980s we saw for the first time descriptions of many of the currently known disorders of fatty acid oxidation; in the 1990s we saw the numbers of known discrete mitochondrial DNA mutations increase rapidly. Some of these diseases are turning out to be relatively common. Medium-chain acyl CoA dehydrogenase (MCAD) deficiency occurs in approximately 10 000 births, and most patients have the same mutation. On the other hand, although it is clear that in the aggregate the inherited diseases of metabolism make up a sizeable portion of human morbidity and mortality, each individual disease tends to be rarely encountered. Even an expert may find years have elapsed since he last saw a patient with a given disorder, reviewed the literature and ordered it in a way that would help with diagnosis or treatment. It helps to have the relevant information in one place for ready retrieval. This atlas serves that purpose for us.We are hopeful that it will do the same for our readers.
The advent of molecular biologic approaches to genetics and the increasing exploration of the human genome have changed forever the scope of human genetics and the manner in which it is practiced. In the Atlas we have endeavored to seek a balance among the molecular biology and the nature of mutation, the enzymology and intermediary metabolism and clinical practice. Our focus is on the clinician. Algorithms are provided for the logical workup of a patient with lactic acidemia, and disorders of fatty acid oxidation and a systematic approach to the diagnosis of a patient with hyperammonemia.
Medical genetics is now officially recognized in many countries among clinical and laboratory specialties. Trainees preparing themselves for board examinations might want to read the Atlas from cover to cover. We hope that in addition to medical geneticists, pediatricians, neurologists, internists, pathologists and all those who interact with patients with these disorders will find the Atlas of assistance in their practices
The field is moving so rapidly it is an experience to keep current in any disease. There is much in this book that is new, different or virtually unique. Certainly, the pictures are for us a resource. Novel mechanisms of disease have been explored. The many enzyme defects in the congenital disorders of glycosylation are becoming known and with this knowledge recognition of some quite different phenotypes. Mutations have now been identified in the genes for the very strange ethylmalonic aciduria whose petechial exacerbations lead regularly to treatment for meningococcemia. The discovery of this gene, ETHE1 by homozygosity mapping illustrates the powerful new influence of molecular biology and the data provided by the human genome project in this field. The function of this mitochondrial protein remains to be determined. Similarly the Sanjad-Sakati and Al Aqeel-Sewairi syndromes, while not metabolic in the old sense were included because they are illustrations of the way in which new molecular techniques are uncovering novel mechanisms of disease. In the Sanjad-Sakati syndrome a phenotype of endocrineopthy and dysmorphic features is caused by mutations in a tubulin-specific chaperone E (TBLE) which is required for proper folding of -tubulin, the first example to be discovered in human disease resulting from mutation inducing defective folding and assembly of the building blocks of microtubules. In the Al Aqeel-Sewairi syndrome the discovery of mutations in the matrix metalloproteinase (MMP-2) gene not only elucidates this vanishing bone syndrome, but has relevance to many disease processes, such as arthritis, tumor invasion and metastasis.
In the glutamylribose-5-pho
Among the challenges for diagnosis and management highlighted in this volume are the disorders of fatty acid oxidation and the lactic acidemias and mitochondrial disease. The latter include the acronymic disorders resulting from mitochondrial DNA mutation and the Pearson syndrome, which may present in infancy as a pure hematologic disorder. It also includes the newly discovered deficiency of DNA polymerase, which results in a mitochondrial DNA depletion syndrome. The newly recognized disorders of creatine synthesis are a challenge for diagnosis. They are sometimes suspected when the urine is analyzed for organic acids and amino acids, and everything is high, because we base our analyses per mole of creatinine. They may be elegantly demonstrated by nuclear magnetic resonance spectroscopy (NMRS).
The chapter was written by Deborah Marsden, a former fellow at UCSD, now on the faculty at Harvard.
The Atlas was generated by our experience with patients with metabolic disease. We are grateful to the many physicians who have referred these patients to us and to those who have shared their illustrations with us.We are appreciative of the help of many of our fellows and colleagues who have helped us care for and study these patients. They include Drs. Nadia Sakati, Richard Hass, Fred Levine, Robert Naviaux, Jon Wolff and Karen McGowan.
Original artwork was done by Mrs. Frances Bakay and The Office
of Learning Resources at UCSD. Images of tandem mass spectrometry
were recovered by Mr. Jon Gangoiti of the Biochemical/Genetics